Correct. With positive trial results as a catalyst, Oncolix could issue additional stock and we could easily still see a parabolic price increase from recent levels.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.